Labcorp is dedicated to helping increase patient and provider awareness about chronic kidney disease. Working with the National Kidney Foundation, we believe testing as early as possible can help inform treatment decisions—helping slow or stop the progression of the disease and reducing the likelihood of cardiovascular and kidney complications.
We strive to serve as a trusted partner for providers and their patients.
Our range of tests deliver results that help detect early-stage disease and inform treatment strategies.
We understand the importance of sharing knowledge and research to collectively improve population health on a global scale.
Hundreds of clinical trials are enrolling patients to evaluate novel strategies that could slow or stop the progression of chronic kidney disease or help manage related complications. We recognize the important role of physicians to explore potential options for their patients and encourage patients to ask their doctors if taking part in a clinical trial is appropriate for their treatment plan.
